DCLK1表达及其在肝脏内胆管癌和双IN阶段的功能意义
Naomi Matsumura Fukushima1, Tomohiko Adachi2, Takayuki Tanaka1
1Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Anticancer research
|May 31, 2024
概括
双丁类激酶1 (DCLK1) 在早期胆管癌中高度表达. 抑制DCLK1抑制了癌细胞的生长,迁移和入侵,这表明DCLK1是肝内胆管癌的潜在治疗标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 胃肠病学 胃肠病学
背景情况:
- 对于某些瘤来说,已知双丁类激酶1 (DCLK1) 在致癌过程中的作用,但其在胆管癌 (ICC) 中的具体参与仍然不清楚.
- 研究DCLK1的表达和功能对于理解ICC发展至关重要.
研究的目的:
- 为了研究DCLK1在正常上皮的表达水平,胆管内皮质瘤 (BilIN) 和肝内胆管癌 (ICC).
- 确定DCLK1对ICC细胞行为的分子影响,包括迁移,入侵和增殖,并评估其作为治疗点的潜力.
主要方法:
- 在正常上皮,Bilin (1-3),和ICC组织中DCLK1表达的免疫组织化学分析.
- 在人类ICC细胞系 (HuCCT1,HuH28) 中使用小干扰RNA (siRNA) 来静止DCLK1的基因.
- 在体外测试包括伤口愈合,细胞入侵和增殖,有或没有DCLK1抑制剂.
主要成果:
- 与正常上皮相比,DCLK1的表达在ICC和Bilin阶段显著更高 (ICC:95%,Bilin阶段:91-100%与NE:62%).
- 在体外,DCLK1基因沉默 (siDCLK1) 显著抑制了癌细胞迁移和入侵.
- 抑制DCLK1以剂量依赖的方式降低了ICC细胞的增殖.
结论:
- 在ICC致癌的早期阶段,DCLK1的表达很高.
- 通过siRNA或化学抑制抑制DCLK1,在体外有效降低了ICC细胞的生长.
- DCLK1代表了一种有前途的分子标,用于开发治疗肝脏内胆管癌的新疗法.
相关概念视频
03:14Notch Signaling Pathway
The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
02:34Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:15M-Cdk Drives Transition Into Mitosis
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
01:12Role Of Notch Signalling In Intestinal Stem Cell Renewal
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...